Related references
Note: Only part of the references are listed.An Update of Radiolabeled Bombesin Analogs for Gastrin-Releasing Peptide Receptor Targeting
Zilin Yu et al.
CURRENT PHARMACEUTICAL DESIGN (2013)
PET imaging with a [68Ga]gallium-labelled PSMA ligand for the diagnosis of prostate cancer: biodistribution in humans and first evaluation of tumour lesions
A. Afshar-Oromieh et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2013)
PSMA as a target for radiolabelled small molecules
Matthias Eder et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2013)
First-in-Man Evaluation of 2 High-Affinity PSMA-Avid Small Molecules for Imaging Prostate Cancer
John A. Barrett et al.
JOURNAL OF NUCLEAR MEDICINE (2013)
99mTc-Labeled Small-Molecule Inhibitors of Prostate-Specific Membrane Antigen for Molecular Imaging of Prostate Cancer
Shawn M. Hillier et al.
JOURNAL OF NUCLEAR MEDICINE (2013)
68Ga-Complex Lipophilicity and the Targeting Property of a Urea-Based PSMA Inhibitor for PET Imaging
Matthias Eder et al.
BIOCONJUGATE CHEMISTRY (2012)
[68Ga]Gallium-labelled PSMA ligand as superior PET tracer for the diagnosis of prostate cancer: comparison with 18F-FECH
A. Afshar-Oromieh et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2012)
64Cu-NO2A-RGD-Glu-6-Ahx-BBN(7-14)NH2: a heterodimeric targeting vector for positron emission tomography imaging of prostate cancer
Andrew B. Jackson et al.
NUCLEAR MEDICINE AND BIOLOGY (2012)
Profiling gastrin-releasing peptide receptor in prostate tissues: Clinical implications and molecular correlates
Marc Beer et al.
PROSTATE (2012)
A dimerized urea-based inhibitor of the prostate-specific membrane antigen for Ga-68-PET imaging of prostate cancer
Martin Schaefer et al.
EJNMMI RESEARCH (2012)
18F, 64Cu, and 68Ga Labeled RGD-Bombesin Heterodimeric Peptides for PET Imaging of Breast Cancer
Zhaofei Liu et al.
BIOCONJUGATE CHEMISTRY (2009)
68Ga-labeled NOTA-RGD-BBN peptide for dual integrin and GRPR-targeted tumor imaging
Zhaofei Liu et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2009)
Dual Integrin and Gastrin-Releasing Peptide Receptor Targeted Tumor Imaging Using 18F-labeled PEGylated RGD-Bombesin Heterodimer 18F-FB-PEG3-Glu-RGD-BBN
Zhaofei Liu et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
Small-Animal PET of Tumors with 64Cu-Labeled RGD-Bombesin Heterodimer
Zhaofei Liu et al.
JOURNAL OF NUCLEAR MEDICINE (2009)
Heterogeneity of Prostate-Specific Membrane Antigen (PSMA) Expression in Prostate Carcinoma with Distant Metastasis
Sebastian Mannweiler et al.
PATHOLOGY & ONCOLOGY RESEARCH (2009)
Expression of the Gastrin-Releasing Peptide Receptor, the Prostate Stem Cell Antigen and the Prostate-Specific Membrane Antigen in Lymph Node and Bone Metastases of Prostate Cancer
Hildo J. K. Ananias et al.
PROSTATE (2009)
Pseudoirreversible Inhibition of Prostate-Specific Membrane Antigen by Phosphoramidate Peptidomimetics
Tiancheng Liu et al.
BIOCHEMISTRY (2008)
Tetrafluorophenolate of HBED-CC:: a versatile conjugation agent for 68Ga-labeled small recombinant antibodies
Matthias Eder et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2008)
Radiohalogenated Prostate-Specific Membrane Antigen (PSMA)-Based Ureas as Imaging Agents for Prostate Cancer
Ying Chen et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
Prostate-specific membrane antigen expression as a predictor of prostate cancer progression
Sven Perner et al.
HUMAN PATHOLOGY (2007)
Radiolabeled RGD-DTPA-Tyr3-octreotate for receptor-targeted radionuclide therapy
B Bernard et al.
CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS (2004)
Share Paper
